Quality Improvement in Neurology: Multiple Sclerosis Quality Measurement Set 2020 Update

Multiple sclerosis (MS) is a disabling immune-mediated disease of the CNS and considered one of the health conditions with the highest annual spending growth paid by both public and private insurance.1 Health care spending in the United States for MS was reported as $13.9 billion in 2016.1 The estimated cumulated (over 10 years) prevalence of MS among adults in the United States in 2010 was approximately 727,000.2 In 2017, that number was substantially higher, approximately 914,000.2,3 The prevalence is higher among women, with a female: male ratio of 2.8.2 Improving high-quality care for these patients can lead to improved outcomes, reduced spending, and better quality of life.

Read article at journal's website

Related Articles

China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations

China faces the greatest challenge from stroke in the world. According to results from the Global Burden of Disease Study 2019, there were 3.94 million…

Responses

Your email address will not be published.